LVCE Stock Overview

Focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach. More details

LVCE fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Shares are highly illiquid

Does not have a meaningful market cap ($11M)

Shareholders have been diluted in the past year

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

LiveCare, Inc. Competitors

Lyra Therapeutics

NasdaqCM:LYRA

US$11.5m

TherapeuticsMD

NasdaqGS:TXMD

US$8.5m

Kiora Pharmaceuticals

NasdaqCM:KPRX

US$9.8m

Gelteq

NasdaqCM:GELS

US$12.5m

Price History & Performance

Summary of share price highs, lows and changes for LiveCare
Historical stock prices
Current Share Price	US$0.0012
52 Week High	US$0.95
52 Week Low	US$0.0007
Beta	0
1 Month Change	-96.88%
3 Month Change	-99.48%
1 Year Change	-99.76%
3 Year Change	-99.96%
5 Year Change	n/a
Change since IPO	-99.94%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	LVCE	US Pharmaceuticals	US Market
7D	-99.3%	-3.9%	-2.2%
1Y	-99.8%	-0.07%	9.5%

Return vs Industry: LVCE underperformed the US Pharmaceuticals industry which returned -0.8% over the past year.

Return vs Market: LVCE underperformed the US Market which returned 6.6% over the past year.

Price Volatility

Is LVCE's price volatile compared to industry and market?
LVCE volatility
LVCE Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.3%
Market Average Movement	6.4%
10% most volatile stocks in US Market	17.4%
10% least volatile stocks in US Market	3.4%

Stable Share Price: LVCE's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine LVCE's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2018	n/a	Cornelius Rockwell	www.livecarehealth.com

LiveCare, Inc. focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach. The company is a real-time health, analytics, service, and monitoring company that provides persons with type II diabetes with solutions. The company was incorporated in 2018 and is based in Venice, Florida.

LiveCare, Inc. Fundamentals Summary

How do LiveCare's earnings and revenue compare to its market cap?
LVCE fundamental statistics
Market cap	US$11.09m
Earnings (TTM)	-US$10.38m
Revenue (TTM)	US$3.60m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is LVCE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LVCE income statement (TTM)
Revenue	US$3.60m
Cost of Revenue	US$11.85m
Gross Profit	-US$8.25m
Other Expenses	US$2.13m
Earnings	-US$10.38m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did LVCE perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/03/14 15:26
End of Day Share Price	2025/03/14 00:00
Earnings	2023/06/30
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

LiveCare, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.